Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BCRXthis companyBioCryst Pharmaceuticals, Inc.	$7.61	6.19×	-13.74×	1.87×	5.71×	-1611.4%	97.8%	39.0%	30.2%	-221.4%	105.2%	20.0%	-3.68×	1×	4.32×	2.06×	0.0%	5	-3.69	2	B-
AVIRAtea Pharmaceuticals, Inc.	$4.42	-1.84×	1.06×	0×	-1.19×	-75.3%	0.0%	0.0%	0.0%	-57.5%	-63.0%	-45.4%	0×	0.58×	0×	7.82×	0.0%	2	1.99	3	B-
VIRVir Biotechnology, Inc.	$13.63	-1.91×	1.09×	12.18×	-1.73×	-733.1%	82.9%	-682.7%	-638.9%	-57.2%	-50.9%	-47.5%	0.24×	0.1×	0×	5.54×	0.0%	3	3.34	2	C
Peer median	—	-1.87×	1.07×	6.09×	-1.46×	-404.2%	41.5%	-341.3%	-319.4%	-57.4%	-57.0%	-46.4%	0.12×	0.34×	0×	6.68×	0.0%	3	2.66	3	—